Dyne Therapeutics
Dyne Therapeutics is a new biotechnology company pioneering targeted therapies for patients with serious muscle diseases. Learn more
Launch date
Employees
Market cap
€3.1b
Enterprise valuation
€2.4b (Public information from Sep 2024)
Share price
$36.41 DYN
Waltham Massachusetts (HQ)
Authorizing premium user...